Flagship Harbor Advisors’s Privia Health PRVA Stock Holding History

Flagship Harbor Advisors’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15	Closed	-$356	–	1793
2025 Q4	$356	Buy	+15	New	+$365	﹤0.01%	2092

Other funds holding PRVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Flagship Harbor Advisors's PRVA Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of Privia Health (PRVA) in Q1 2026, closing a stake of 15 shares — an estimated $356 sold.

Flagship Harbor Advisors first reported a position in PRVA in Q4 2025 and held it in 1 quarter. The position peaked at $356 in Q4 2025. 293 funds tracked by Wall St. Rank hold PRVA as of Q1 2026.

Flagship Harbor Advisors reported no remaining Privia Health position as of Q1 2026 after selling out during the quarter.
Flagship Harbor Advisors sold 15 Privia Health shares in Q1 2026, an estimated $356.
Flagship Harbor Advisors first reported a position in Privia Health in Q4 2025 and held it in 1 quarter.
Flagship Harbor Advisors's Privia Health position peaked at $356 in Q4 2025.
293 funds tracked by Wall St. Rank held Privia Health as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.